MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
10.72
+0.21 (2.00%)
At close: May 15, 2026, 4:00 PM EDT
10.07
-0.65 (-6.11%)
After-hours: May 15, 2026, 7:14 PM EDT
MiNK Therapeutics Market Cap
MiNK Therapeutics has a market cap or net worth of $53.41 million as of May 15, 2026. Its market cap has increased by 80.80% in one year.
Market Cap
53.41M
Enterprise Value
44.18M
1-Year Change
80.80%
Ranking
Category
Stock Price
$10.72
Market Cap Chart
Since the IPO on October 15, 2021, MiNK Therapeutics's market cap has decreased from $386.36M to $53.41M, a decrease of -86.18%. That is a compound annual growth rate of -35.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 44.88M | -9.41% |
| Dec 31, 2025 | 49.54M | 79.26% |
| Dec 31, 2024 | 27.64M | -25.26% |
| Dec 29, 2023 | 36.98M | -58.09% |
| Dec 30, 2022 | 88.23M | -40.95% |
| Dec 31, 2021 | 149.43M | -61.32% |
| Oct 15, 2021 | 386.36M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lixte Biotechnology Holdings | 58.55M |
| KALA BIO | 57.44M |
| iBio, Inc. | 56.38M |
| aTyr Pharma | 54.90M |
| Instil Bio | 54.56M |
| Cingulate | 53.78M |
| Xilio Therapeutics | 52.71M |
| Hyperion DeFi | 51.43M |